Dr. Francoeur has been an attending physician in both internal medicine and critical care, as well as a clinical professor at the CHU de Québec – Laval University, since 2014. He joined the Population Health and Optimal Health Practice Research Unit at the CHU de Québec-Laval University in 2017 as a research associate. After receiving his medical degree in 2007 from Université de Sherbrooke, he trained in internal medicine at Laval University in Quebec, and in critical care medicine at the University of Montreal. He completed his master’s degree in epidemiology at the Columbia University of New York in 2016, as well as a clinical fellowship training in neurocritical care at Mount Sinai Hospital, also in New York.
Dr. Francoeur’s research focuses mainly on neurocritical care. Treatment and prevention of secondary insults in patients suffering severe brain injury and optimization of neuroresuscitation are the mainstay of his research efforts.
1401, 18e Rue
Québec, Québec
Canada G1J 1Z4
Latest news
Data not available
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Journal ArticleJAMA, 329 (1), 2023.
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Journal ArticleN Engl J Med, 386 (25), 2022.
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial
Journal ArticleJAMA, 327 (21), 2022.
Near Infrared Spectroscopy for Poor Grade Aneurysmal Subarachnoid Hemorrhage-A Concise Review
Journal ArticleFront Neurol, 13 , 2022.
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
Journal ArticleJAMA, 326 (17), 2021.
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Journal ArticleNat Med, 27 (11), 2021.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Journal ArticleIntensive Care Med, 47 (8), 2021.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Journal ArticleN Engl J Med, 385 (9), 2021.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Journal ArticleN Engl J Med, 385 (9), 2021.
Acute Blood Pressure and Outcome After Intracerebral Hemorrhage: The VISTA-ICH Cohort
Journal ArticleJ Stroke Cerebrovasc Dis, 30 (1), 2021.
Active projects
- BRAINapt: TBI International Platform Trial, from 2023-10-01 to 2024-03-31
- The NeurO2 study: optimal brain oxygenation in neurocritically ill patients, from 2020-10-01 to 2024-03-31